Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?
View/
Access
info:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivs 3.0 United Stateshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/Date
2023Metadata
Show full item recordCitation
Akşit E, Köder A. (2023) Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?. Balkan Medical Journal, 40(3), 228. doi: 10.4274/balkanmedj.galenos.2023.2023-3-15Abstract
To the Editor, The Coronavirus disease-2019 (COVID-19) has caused a global pandemic.1 A recent study suggested that the prevalence of cardiomyocyte injury and microvascular thrombogenicity was lower in the second wave of the COVID-19 pandemic compared with the first wave.2 The importance of agents such as ticagrelor for reducing thromboembolic events in COVID-19 has also been noted.3 A recent study suggested that the UGT2A1/UGT2A2 genes are responsible for the olfactory dysfunction (OD) attributed to COVID-19.4 Interestingly, UGT2A1 polymorphisms are known to be associated with platelet reactivity.5
Volume
40Issue
3URI
https://doi.org/10.4274/balkanmedj.galenos.2023.2023-3-15https://hdl.handle.net/20.500.12428/5265
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
